these results demonstrate that kt-362 has a favorable effect on the functional recovery of the ischemic-reperfused myocardium and incidence of ventricular fibrillation , and may be of potential benefit as a new therapeutic agent for the treatment of coronary heart disease .
C0018799
the
C0018787
heart